Logos Global Management LP 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 3:53 pm Sale | 2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Logos Global Management LP | 2,150,000 4.100% | -804,392 (-27.23%) | Filing |
| 2022-02-14 4:10 pm Sale | 2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN | Logos Global Management LP | 2,954,392 5.700% | -940,000 (-24.14%) | Filing |
| 2021-08-16 2:37 pm Purchase | 2021-08-05 | 13G | Dyne Therapeutics, Inc. DYN | Logos Global Management LP | 3,894,392 7.600% | 3,894,392 (New Position) | Filing |